These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25770350)

  • 1. RGC-32 is a novel regulator of the T-lymphocyte cell cycle.
    Tegla CA; Cudrici CD; Nguyen V; Danoff J; Kruszewski AM; Boodhoo D; Mekala AP; Vlaicu SI; Chen C; Rus V; Badea TC; Rus H
    Exp Mol Pathol; 2015 Jun; 98(3):328-37. PubMed ID: 25770350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol 3-kinase inhibitors prevent mouse cytotoxic T-cell development in vitro.
    Phu T; Haeryfar SM; Musgrave BL; Hoskin DW
    J Leukoc Biol; 2001 May; 69(5):803-14. PubMed ID: 11358990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-1BB signaling activates the t cell factor 1 effector/β-catenin pathway with delayed kinetics via ERK signaling and delayed PI3K/AKT activation to promote the proliferation of CD8+ T Cells.
    Lee DY; Choi BK; Lee DG; Kim YH; Kim CH; Lee SJ; Kwon BS
    PLoS One; 2013; 8(7):e69677. PubMed ID: 23874982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSC1/2 signaling complex is essential for peripheral naïve CD8+ T cell survival and homeostasis in mice.
    Zhang L; Zhang H; Li L; Xiao Y; Rao E; Miao Z; Chen H; Sun L; Li H; Liu G; Zhao Y
    PLoS One; 2012; 7(2):e30592. PubMed ID: 22363451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased PKG transcription mediated by PI3K/Akt/FoxO1 pathway is involved in the development of nitroglycerin tolerance.
    An YM; Li YJ; Zhang CL; Cong X; Gao YS; Wu LL; Dou D
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1195-1201. PubMed ID: 30554658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrophilin Btn2a2 inhibits TCR activation and phosphatidylinositol 3-kinase/Akt pathway signaling and induces Foxp3 expression in T lymphocytes.
    Ammann JU; Cooke A; Trowsdale J
    J Immunol; 2013 May; 190(10):5030-6. PubMed ID: 23589618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin-3-gallate directly suppresses T cell proliferation through impaired IL-2 utilization and cell cycle progression.
    Pae M; Ren Z; Meydani M; Shang F; Meydani SN; Wu D
    J Nutr; 2010 Aug; 140(8):1509-15. PubMed ID: 20534878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vav1 promotes T cell cycle progression by linking TCR/CD28 costimulation to FOXO1 and p27kip1 expression.
    Charvet C; Canonigo AJ; Bécart S; Maurer U; Miletic AV; Swat W; Deckert M; Altman A
    J Immunol; 2006 Oct; 177(8):5024-31. PubMed ID: 17015685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The poststimulation program of CD4 versus CD8 T cells (death versus activation-induced nonresponsiveness).
    Tham EL; Mescher MF
    J Immunol; 2002 Aug; 169(4):1822-8. PubMed ID: 12165505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 responsiveness of CD4 and CD8 lymphocytes: further investigations with human IL-2Rbeta transgenic mice.
    Gesbert F; Moreau JL; Thèze J
    Int Immunol; 2005 Aug; 17(8):1093-102. PubMed ID: 16037071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.
    Aragoneses-Fenoll L; Montes-Casado M; Ojeda G; Acosta YY; Herranz J; Martínez S; Blanco-Aparicio C; Criado G; Pastor J; Dianzani U; Portolés P; Rojo JM
    Biochem Pharmacol; 2016 Apr; 106():56-69. PubMed ID: 26883061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
    Carter L; Fouser LA; Jussif J; Fitz L; Deng B; Wood CR; Collins M; Honjo T; Freeman GJ; Carreno BM
    Eur J Immunol; 2002 Mar; 32(3):634-43. PubMed ID: 11857337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
    Chi PD; Li L; Fan YY; Wu CY
    Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rottlerin inhibits human T cell responses.
    Springael C; Thomas S; Rahmouni S; Vandamme A; Goldman M; Willems F; Vosters O
    Biochem Pharmacol; 2007 Feb; 73(4):515-25. PubMed ID: 17141738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation of murine c-kit(pos) cardiac stem cells stimulated with IGF-1 is associated with Akt-1 mediated phosphorylation and nuclear export of FoxO3a and its effect on downstream cell cycle regulators.
    Johnson AM; Kartha CC
    Growth Factors; 2014 Apr; 32(2):53-62. PubMed ID: 24580070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis.
    Kim KW; Cho ML; Park MK; Yoon CH; Park SH; Lee SH; Kim HY
    Arthritis Res Ther; 2005; 7(1):R139-48. PubMed ID: 15642134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells.
    Abid MR; Guo S; Minami T; Spokes KC; Ueki K; Skurk C; Walsh K; Aird WC
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):294-300. PubMed ID: 14656735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immature CD4+CD8+ thymocytes do not polarize lipid rafts in response to TCR-mediated signals.
    Ebert PJ; Baker JF; Punt JA
    J Immunol; 2000 Nov; 165(10):5435-42. PubMed ID: 11067895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dominant-negative mutant of c-Jun inhibits cell cycle progression during the transition of CD4(-)CD8(-) to CD4(+)CD8(+) thymocytes.
    King LB; Tolosa E; Lenczowski JM; Lu F; Lind EF; Hunziker R; Petrie HT; Ashwell JD
    Int Immunol; 1999 Aug; 11(8):1203-16. PubMed ID: 10421778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.